Oncology and Hematology - Global Oncology Academy

145-160 of 790

Breast Cancer Survivorship: Why Lifestyle Medicine Matters
Breast Cancer Survivorship: Why Lifestyle Medicine Matters
Project Oncology®
Breast Cancer Survivorship: Why Lifestyle Medicine Matters
Amy Comander, MD
- Amy Comander, MD
Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
MinuteCE®
Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
Jennifer Johnson, MD, PhD
0.50 program credits
- Jennifer Johnson, MD, PhD
0.50 program credits
Reducing the Rise of Uterine Cancer in the United States
Reducing the Rise of Uterine Cancer in the United States
Project Oncology®
Reducing the Rise of Uterine Cancer in the United States
Charles Turck, PharmD, BCPS, BCCCP; Richard T. Penson, MD, MRCP
- Charles Turck, PharmD, BCPS, BCCCP
- Richard T. Penson, MD, MRCP
Emerging TNBC Research: Biomarkers, Genomics, and Adaptive Treatment
Emerging TNBC Research: Biomarkers, Genomics, and Adaptive Treatment
Project Oncology®
Emerging TNBC Research: Biomarkers, Genomics, and Adaptive Treatment
Roberto Leon-Ferre, MD
- Roberto Leon-Ferre, MD
Impact of Infertility & Elective Fertility Among Female Oncologists
Impact of Infertility & Elective Fertility Among Female Oncologists
Project Oncology®
Impact of Infertility & Elective Fertility Among Female Oncologists
Emily MacDuffie, MD
- Emily MacDuffie, MD
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
MinuteCE®
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
Adam J. Luginbuhl, MD; Jennifer Johnson, MD, PhD
0.50 program credits
- Adam J. Luginbuhl, MD
- Jennifer Johnson, MD, PhD
0.50 program credits
Redefining Cancer Care with Functional Precision Medicine
Redefining Cancer Care with Functional Precision Medicine
Project Oncology®
Redefining Cancer Care with Functional Precision Medicine
Matt Birnholz, MD; Jim Foote, MBA
- Matt Birnholz, MD
- Jim Foote, MBA
Managing Early Esophageal and Gastric Cancers: ASGE Recommendations on ESD and EMR
Managing Early Esophageal and Gastric Cancers: ASGE Recommendations on ESD and EMR
GI Insights
Managing Early Esophageal and Gastric Cancers: ASGE Recommendations on ESD and EMR
Peter Buch, MD, FACG, AGAF, FACP; Vivek Kaul, MD
- Peter Buch, MD, FACG, AGAF, FACP
- Vivek Kaul, MD
Survival Outcomes in Squamous Cell Carcinoma of the Anal Canal: POD1UM-303 Data
Survival Outcomes in Squamous Cell Carcinoma of the Anal Canal: POD1UM-303 Data
Project Oncology®
Survival Outcomes in Squamous Cell Carcinoma of the Anal Canal: POD1UM-303 Data
Brian P. McDonough, MD, FAAFP; Stacey Cohen, MD
- Brian P. McDonough, MD, FAAFP
- Stacey Cohen, MD
Optimizing cGVHD Treatment Decisions in the Second- and Third-Line Settings
Optimizing cGVHD Treatment Decisions in the Second- and Third-Line Settings
Project Oncology®
Optimizing cGVHD Treatment Decisions in the Second- and Third-Line Settings
Charles Turck, PharmD, BCPS, BCCCP; Stephanie Gregory, CNP
- Charles Turck, PharmD, BCPS, BCCCP
- Stephanie Gregory, CNP
Communicating Pathologic Response Results in Resectable NSCLC
Communicating Pathologic Response Results in Resectable NSCLC
Project Oncology®
Communicating Pathologic Response Results in Resectable NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Alexander Spira, MD, PhD, FACP
- Charles Turck, PharmD, BCPS, BCCCP
- Alexander Spira, MD, PhD, FACP
- Robert Merritt, MD
Managing High-Risk Subgroups in Metastatic NSCLC
Managing High-Risk Subgroups in Metastatic NSCLC
Project Oncology®
Managing High-Risk Subgroups in Metastatic NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Melina Marmarelis, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Melina Marmarelis, MD
- Deepa Rangachari, MD
Managing Immune-Related Adverse Events in Metastatic NSCLC
Managing Immune-Related Adverse Events in Metastatic NSCLC
Project Oncology®
Managing Immune-Related Adverse Events in Metastatic NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Paul Bunn, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Paul Bunn, MD
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Project Oncology®
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Deepa Rangachari, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Deepa Rangachari, MD
Real-World Strategies for Complex cGVHD Treatment Decisions
Real-World Strategies for Complex cGVHD Treatment Decisions
Project Oncology®
Real-World Strategies for Complex cGVHD Treatment Decisions
Brian P. McDonough, MD, FAAFP; Doris M. Ponce, MD, MS
- Brian P. McDonough, MD, FAAFP
- Doris M. Ponce, MD, MS
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Project Oncology®
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Charles Turck, PharmD, BCPS, BCCCP; Laura Alder, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Laura Alder, MD
- Christine Bestvina, MD

Previous
1
2
…
8
9
10
11
12
…
49
50
Next

10/11